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Abstract 
Objective: Analysis of the alleged connection between the periodontal and cardiovascular disease, with reference 
to periodontal pathogens as a risk factor for heart disease.
Researching method: A research was carried out at Medline/Pubmed. Included criteria and researching strategy. 
The articles selection has been made taking into account key-terms appearing either in the title or in the summary. 
Experimental studies in animals, clinical prospective studies performed with a minimum sample size (>30) and stu-
dies written in English have been included. The rejected criteria were the following: clinical retrospective studies 
and/or studies carried out with a low sample size (n<30).
Results: Within systemic diseases related to periodontal ones, the alleged link between periodontal and heart and 
circulatory disease has been one of the most investigated in recent times. Different authors consider the existence 
of a link between the diseases as such, inappropriate and implausible since both the diseases have risk factors in 
common (age, gender, smoking, diet, oral hygiene and diabetes). However, speculations about the origin of the 
diseases were raised when it was demonstrated that some bacteria species, bacteria proteins and lipopolysaccharide 
are present at the plaques of atherosclerosis that obstruct the coronary arteries. The mechanisms of this connection 
have been analyzed following an actualized review.
Conclusion: Most of the experimental and clinical studies ensure that a positive association between periodontal 
disease and heart disease has been found, once the con-founder factors have been eliminated.
Key words: Periodontal disease, cardiovascular disease, atheroma, oral pathogens, Actinobacillus Actinomyc-
etemcomitans (Aa), Porphyromonas gingivalis (Pg).
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Introduction
In the last decade the expert’s attention to the significan-
ce that oral health can have in atherosclerosis is raising. 
Cardiovascular diseases are secondary to atherosclero-
sis. Within cardiovascular diseases, heart related ones 
are noted. Ischemic cardiomyopathy is the most im-
portant sign that defines coronary artery disease (1, 2). 
Nowadays, heart diseases are the major cause of death in 
developed countries (1).
The classic risk factors related to these diseases have 
been identified as age, sex, heredity, diet, diabetes, high 
blood pressure, exercising and smoking. At present many 
studies show that inflammatory diseases with a chronic 
basis increase the risk of suffering from cardiovascular 
diseases. This is the reason why within the past decades 
researches on chronic infections effects on coronary pa-
thogenesis have increased (3-6). 
The mechanism whereby chronic infections increase the 
risk of suffering atherosclerosis or thrombosis is unclear, 
nonetheless it is believed that the requirement is a long-
term systemic exposure to the pathogens (7-15).
A periodontal disease causes a sort of chronic inflamma-
tion (3) which provides bacteria and their components a 
direct access to the bloodstream, to which is added the 
micro ulceration of the epithelium of the periodontal 
pocket (4,16,17). The contact between germs and ma-
crophages causes a direct release of pro-inflammatory 
mediators (IL-8, TNFα), that facilitates the attraction of 
neutronphils from vessels (innate immunity). The FNTα 
favors increased hepatic synthesis of LDL cholesterol. 
Equally, IL-6 is released later which helps the produc-
tion of C-reactive protein (CRP) in the liver. This fact 
accellerates the atherosclerosis plaque progression.
Thereby, it seems that periodontal diseases could be an 
additional factor for the atherosclerosis development. 
Nevertheless, not all studies have stated that they have 
found causality, owing to the multi-factorial nature of 
both dental infection and cardiovascular disease and to 
the confusion factors adjustment that should be conside-
red in every study. The primary aim of this review was to 
analyze the assumed connection between periodontitis 
and cardiovascular diseases. In this respect the analysis 
has been focused on the relevance of periodontal germs 
as a cardiovascular risk factor.
Material and methods
A research was carried out at Medline/Pubmed (http://
medline.cos.com) with the following keywords: oral pa-
thogens OR Actinobacillus actinomycetemcomitans OR 
Porphyromonas gingivalis AND cardiovascular disease.
Taken in criteria and research method: The articles se-
lection has been made taking into account key-words ei-
ther in the title or in the summary. Experimental studies 
in animals, clinical prospective studies performed with 
a minimum sample size (>30) and studies written in En-
glish have been included. Clinical retrospective studies, 
studies carried out with a low sample size (n<30) and 
non English language written studies were rejected.
Literature review 
In the last decade, many epidemiological studies have 
brought to light that oral infections, especially PD, can 
act as independent risk factor for several systemic disea-
ses, like the CVD. It has been argued that mediators of 
inflammation in PD are the same involved in other chro-
nic diseases such as CVD. The cause-effect relationship 
between the two processes is being studied with great 
interest (1). Inflammations appear to play a significant 
role in the pathogenesis of atherosclerosis. Low-grade 
chronic inflammatory processes could be involved in the 
development of this course. The PD is caused by a chro-
nic infection associated with elevated CRP and other in-
flammatory biomarkers. 
Histopathology and pathophysiology of atherosclerosis 
by periodontal inflammation: etiopathogenic models
When there is an initial damage of the endothelium, en-
dothelial cells generate adhesion molecules called vas-
cular cell adhesion molecules (VCAM) and intercellular 
adhesion molecules (ICAM) (1, 16, 17). As a result the 
endothelium starts being attacked by leukocytes. Endo-
thelial permeability to lipids (LDL cholesterol) increases, 
and production of cytokines/chemokines is enhanced as 
well as growth factors that at the same time stimulate 
monocytes/macrophages. Cytokines boost the attrac-
tion of polymorphonuclear cells (PMN) (2) as well, and 
the migration of smooth muscle cells, which respond to 
inflammatory stimuli by the secretion of metalloprotei-
nases that are capable to degrade elastin and collagen 
(18,19). Thereby, the fibrous capsule that maintained the 
plaque attached to the artery wall can break and detach, 
increasing in this way the risk of thrombosis, embolisms 
and strokes. Atherosclerosis is a chronic inflammatory 
disorder characterized by the accumulation of mono-
cytes/macrophages, lipids (LDL cholesterol), smooth 
muscle cells and lymphocytes within the arterial wall in 
response to the release of pro-inflammatory molecules. 
Thus, the host immune system plays an essential role in 
the development of the atherosclerotic plaque. This can 
be stimulated by certain molecules of the host, such as 
oxidized low-density lipoprotein (oxLDLs), lipoprotein 
a (Lpa) or foreign antigens, including the ones of certain 
bacteria (7).
Oral pathogens in atheromatous plaque
The most typical oral pathogens associated with human 
PD are Porphyromonas gingivalis (Pg), Actinobacillus 
actinomycetemcomitans (Aa) and Streptococcus san-
guis (Ss), which can all invade the junctional epithelium 
and gain access to the systemic circulation.
Possible mechanisms by which oral pathogens can con-
tribute to CVD are by a direct effect on the formation of 
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CVD (by a direct effect). The Pg possesses numerous 
virulence factors such as proteases, lipopolysaccharides, 
capsular polysaccharides, hemagglutinins and fimbriae 
(12). In vitro studies have shown that the fimbriae of 
this microorganism plays a pivotal role in the invasion 
and adhesion to endothelial cells (10), in stimulating the 
production of cell adhesion molecules (VCAM) and the 
expression of chemokines (13). In addition, the Pg is a 
producer of proteases that can activate platelet aggrega-
tion and stimulate the coagulation cascade. Thereby it 
contributes to the disruption of the atherosclerotic plaque 
and thrombotic complications (1, 10). Platelet receptors 
have been described for a PG antigen (14). This fact 
would determinate their aggregation, the capability of 
some periodontal pathogens to invade the endothelium 
and their DNA presence at the atheromatous plaque. Lo-
urbakos et al. (14) found an association between Pg and 
the atherosclerotic plaque in the endothelium; by an in-
direct effect mediated by the host immune response (5); 
or by a genetic predisposition for pathogenesis (1).
Some academics found a causal relationship between 
PD and CVD. They support the etiopathogenic model 
in which periodontal bacteria such as Aa and Pg, once in 
the bloodstream (bacteremia), would stimulate by an in-
direct effect the release of antibodies (5), cytokines and 
other pro-inflammatory mediators such as CRP or TNFα 
(6). They would be responsible for initiating a cascade 
of biochemical reactions, causing endothelial damage 
and ultimately facilitating the genesis of the atheroscle-
rotic plaque (1).
Other studies have pointed out the presence of Pg at the 
atheromatous plaque (3, 7-11). This microorganism en-
ters the vascular system and settles in areas of the deve-
loping atherosclerotic plaque. This could aggravate the 
Authors Type  
study
(n) CV
parameters
Periodontal
parameters
Confounding factors
Yamazaki et 
al. (2007) Pc-c
CHD: 51; 
PD: 55; 
healthy: 37
Chronic sta-
ble angina/ 
ACS
PD, JEL, BL, nº 
teeth
-Age - gender - smoking, - lipid pro-
file - antibodies
Spar et al.
(2006)
Pc-c CHD: 263; C:526 
Stable CHD/ 
history MI/ 
history  HBP
CPITN, SBS
-Age - gender - smoking - BMI - al-
cohol - hyperlipoproteinemia - dia-
betes mellitus - exercising - choles-
terol - school education
Pussinen et al. 
(2003) P 1163 CHD Teeth (n)
-Smoking - alcohol - HBP -  lipid 
profile - cholesterol - education 
Ishihara et al.
(2004) Pd-b CHD: 51
Plaques in 
CA
PD, periodontal 
lesions, SBS -
Pussinen et al.
(2004) Pc-c 6950 Histroy MI/ CHD -
-Age - gender - smoking - HBP - 
BMI - alcohol - diabetes - choles-
terol
Beck et al.
(2005) Pc 15792 CHD history SBS, CFS, PD
-Age - gender - smoking - HBP - 
diabetes - LDL/HDL cholesterol - 
rece
Pussinen et al. 
(2007) Pc 6051
CHD preva-
lence/ CHD 
inc idence / 
n o n - C H D 
death.
- -Age - gender - total serum choles-terol - HDL
Demmer et al. 
(2010) Pc 706 CHD
Nº teeth, PD, 
gingival margin 
location, BL,Pd.
-
Sakurai et al.
(2007) P CHD: 28 Ca measure PD, B -
Table 1. Description of the most relevant clinical studies.
P: Prospective; P c-c: Prospective case- control; Pc: Prospective cohort; Pb: Prospective double blind C: control; CHD: Coronary heart disea-
se; ACS: Acute Coronary Syndrome; MI: myocardial infarction ; Ca: coronary angiography; CA: coronary arteries; CPITN: Community Perio-
dontal Index of Treatment Needs; HBP: high blood pressure; SP: systolic pressure ; HDL: high density lipoprotein cholesterol; LDL: low density 
lipoprotein cholesterol; BMI: body mass index; CRP: C-reactive protein; PD: probing depth; Pd: pocket depth; BL: bone loss; B: Bleeding; JEL: 
junctional epithelium level; SBS: subgingival biofilm sample; CFS: crevicular fluid samples
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CVD through the production of a proteinase (arginine-
gingipains) that can activate protease receptors PAR-1 
and PAR-4 which are evidenced on the platelet surface.
In a recent study, Roth et al. (11) discussed for the first 
time the capability of the Pg to invade smooth muscle 
cells of blood vessels and modulate the production of the 
Tissue Factor (TF) and its inhibitor (TFPI). They found 
that the Pg was able to decrease the production and acti-
vity of TFPI and enhance the production and activity of 
TF. They noticed that this periodontal pathogen has pro-
thrombotic effects by acting on smooth muscle cells, 
modulating the production TFPI. From another clinical 
study emerged that hemagglutinins are involved in the 
adhesion of Pg to endothelial cells of human coronary 
arteries (15).
Experimental studies on animals
Experimental studies have been useful to clarify the pa-
thogenic models of bacterial action on atherogenesis. 
Some in vivo studies on animals (10, 13, 20, 22) disco-
vered that individuals who were inoculated periodontal 
microorganisms had more advanced and larger atheros-
clerotic lesions, which were developed before, than the 
animals from the control group. 
Genco et al. (2) suggested that Pg infection, which is one 
of the most important pathogens associated with human 
PD, activates the acute response of systemic inflamma-
tion, increases lipaemia and enhances atherosclerotic 
lesion formation in ApoE (+/-) mice (heterozygous ge-
notype).
Chi et al. (18) observed on their experimental study on 
mice that interleukin 1 (IL-1) promotes atherogenesis. 
This is due to the analysis of post-mortem atheromatous 
plaque samples, which indicated that mice without IL-1 
receptor (ApoE +/-/IL-1R1 -/-) had smaller atheroma-
tous lesions than ApoE +/-/IL-1R1 +/- mice. Madan et 
al. (19) experimented about ApoE (+/-) mice as well. 
They found that ApoE +/-/IL-6 -/- mice had a signifi-
cant increase on the aortic atheromatous lesions, higher 
levels of acute coronary syndrome (ACS) and pro-in-
flammatory cytokines compared with ApoE +/-/IL-6 +/- 
group. These results insinuate that IL-6 has a protective 
function against atherosclerosis. Miyamoto et al. (17) 
became aware of more advanced atheromatous damages 
at hyper-lipemic mice.
In addition, Brodala et al. (20) detected Pg DNA at athe-
romatous plaques on carotid and aortic artery vascular 
tissues in pigs. These animals were given a high-fat diet 
and were inoculated a Pg infection. Bacteremia by Pg 
induced atherosclerosis in pigs with normal cholesterol 
levels, and increased atherosclerosis in pigs with high 
cholesterol levels. It seemed that PD enhanced the accu-
mulation of lipids in vivo, due to chronic inflammation.
Therefore, it is believed that the infectious agent by it-
self does not cause atherosclerosis, but it does contribu-
te to accelerate its progression when this damage is al-
ready formed (21). In another study on animals (13), the 
experts checked also that immunization (vaccination) 
against Pg prevents the atherosclerosis acceleration.
However, not all the studies proof finding this causality. 
Miyamoto et al. (17) for instance, could not demonstrate 
during their experimental study on mice that infection 
by Pg could cause an important systemic inflammatory 
reaction. They studied the levels of IL-6 and Amyloid 
A (the equivalent of CRP in humans) on serological 
samples of Pg infected and non-infected mice, and they 
found very similar levels on both groups.
Clinical studies on humans 
Several clinical studies on humans reveal that some pa-
thogens of bacterial plaque have a direct effect on athe-
rosclerosis even though some study designs are more 
appropriate than others when it comes to look for the 
causality relation between PD and CVD (Table 1).
Meurman et al. (1) summarize on their literature review 
the necessary criteria to establish the causality between 
these phenomena (PD-CVD) (Table 2).
IgG antibody measurement is one of the most used fac-
tors with the aim of setting a causal link between PD and 
atherosclerosis. In some studies they took samples from 
sub-gingival biofilm and made a serologic analysis, in 
which they detected antibodies against periodontal pa-
thogens (3, 5, 22-24). An association between these 
pathogens and atherosclerosis (coronary disease speci-
fically) was found after adjusting other risk factors for 
CVD. However, this fact could not prove a cause-effect 
relation.
Pussinen et al. (5), on their transversal cohort study, 
found a link between IgG against Pg and Aa, and ische-
mic cardiopathy (IC). They noticed greater prevalence 
of IC in those subjects with high IgG levels than in those 
with low levels. They related edentulism and seropositi-
vity to Pg with IC. With lineal regression, they observed 
that the antibody reaction was associated directly with 
the prevalence of IC. Sakurai et al. (16) thought that Aa 
could play a determinant role in the development of acu-
te coronary syndrome (ACS). This is because they found 
Aa at the oral plaque samples taken from subjects with 
ACS. Contrastingly, the counts were negative in subjects 
who suffered chronic ischemic cardiopathy (CIC).
Demmer et al. (25), in a very recent cohort prospective 
study, analyzed the periodontal infection as a risk factor 
for CVD, by the study of periodontal clinical parame-
ters, using them as a substitute for the underlying bac-
terial exposure. They found that the periodontal clinical 
measures which demonstrated greater link with bacte-
ria charges were: rate of bleeding points after probing 
(r=0.62); number of locations with bleeding after pro-
bing (r=0.59) and rate of locations with probing depth 
(PD) ≥ 3 mm (r=0.61), whereas PD ≥ 8 mm, r=0.16. This 
fact could demonstrate that the clinical definition for PD 
should include the low-depth periodontal pocket measu-
e480
J Clin Exp Dent. 2011;3(5):e476-82.                                 Periodontal microorganisms as a risk factor for heart disease.
res in order to show better the relationship between PD 
and bacteria rates.
Pussinen et al. (6) carried out a cohort prospective stu-
dy with a sample of 6,051 participants with the aim of 
relating serologic endotoxins, IgG against periodontal 
pathogens and inflammation markers (IL-6, CRP) in re-
lation with CVD. They took samples of endotoxins and 
serologic antibodies from 784 collaborators. High levels 
of endotoxins were related positively with diastolic pres-
sure, total cholesterol, body mass index (BMI) and IgG 
against Pg. During ten years of monitoring, they realized 
that those individuals who suffered any episode of CVD 
had higher blood levels of endotoxins. High concentra-
tion of endotoxins, antibodies, CRP and IL-6 are directly 
associated with cardiovascular episodes when adjusted 
by age and gender. They came to the conclusion that 
high IgG levels against Aa and Pg could be considered 
as a cardiovascular risk factor in the future, researchers 
studied people who had suffered myocardial infarction 
(MI), and they found a serological evidence of an asso-
ciation with PD (4).
In another cohort prospective study (6) the atheromatous 
plaques of 51 patients, which had to be operated surgi-
cally, were analyzed. The presence of 5 microorganisms 
come into view in both the atheromatous plaque of the 
coronary arteries and the subgingival plaque: Aa, Pg, 
Bacteroides forsythus, Treponema denticola and Cam-
pylobacter rectus. Therefore, PD was related directly to 
the detection of periodontal bacteria DNA in atheroma-
tous lesions. The DNA identification of those pathogens 
at the atheromatous plaque was carried out with poly-
merase chain reaction (PCR), immunofluorescence and 
electronic microscopy techniques (3, 8).
It seems that atherosclerosis is an inflammatory nature 
disease more than a disease caused by an excess in li-
pid deposit. Equally, PD is a consequence of the host 
inflammatory reaction more than a direct destruction 
from the pathogens infection. It has been observed that 
chronic infections cause possible bacteremia which lead 
to the attack and activation of endothelial cell inflamma-
tion caused by periodontal pathogens as Pg. The studies 
accomplished, however, have not been able to isolate 
viable bacteria, but just their sequence of nucleic acids. 
This supports the evidence that chronic infections help 
generate a modification in the regulation of the inflam-
matory response. This in turn provokes a further altera-
tion of endothelial cells on the one hand and acceleration 
in the formation of atheromatous plaques on the other 
(26). In PD there would be an over regulation of certain 
inflammation markers such as CRP or soluble E-selec-
tin. By reducing these bio-markers and controlling local 
and systemic inflammation, endothelial dysfunction and 
the risk of CVD would decrease (26, 27).
At the vessel wall, after endothelial injury, monocytes 
and lymphocytes migrate into the blood vessel wall, 
led by inflammation signs. Then monocytes differ into 
macrophages, which recognize and phagocytose LDL-
cholesterol particles. These monocytes, process and pre-
Interpretation Comments
Temporal relationship: Does the predictor occur before 
the results?
This criterion must be met in any case.
Response according to the dose: When there is greater severity of 
the predictor, are there more se-
vere results?
This is not always the case. Some causal 
relationships occur in a threshold at which 
the results can be different: illness or dis-
ease.
Strength of association: Is the morbidity rate higher in the 
exposed tan in unexposed?
Some risk factors generate very high-risk 
relationship 
(e.g. smoking).
Consistence: Do the investigations carried out 
in different countries, groups or 
institutions generate similar re-
sults?
Results could not be consistent, due to 
the investigation methods (clinical or 
epidemiological) or to the adjustment for 
confounding factors. Especially if the pre-
dictor is weak and the confounding factors 
are strong. (Pay special attention to the 
false “true associations”)
Biology: Does it make biological sense? The pathogenesis is important. Do we 
have a solid biological reason to believe 
that there is a causation or association? 
This must always be complied. 
Table 2. Criteria for establishing a causal association. Table of Hennekens and Buring (1987), adjusted by Meurman JH.
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sent the protein component of LDL particles as a pep-
tide to T-lymphocytes, by the major histocompatibility 
complex II (MHC II). Other antigens, own or strangers, 
which have access to the vessel wall as well, could tri-
gger a similar mechanism. It is believed that most lym-
phocytes differ in situ into effector T- lymphocytes, un-
der the influence of stimuli from specific antigens; this, 
nevertheless still needs to be proved. Once they have 
been activated, macrophages and lymphocytes initiate 
the release of pro-inflammatory molecules (chemoki-
nes), which can stimulate the migration of smooth mus-
cle cells from the intermediate layer of the vessel. This, 
together with the formation of foamy cells, is going to 
initiate the formation of the fibrous layer. This process is 
facilitated by cytokines such as TNFα and IL-12, secre-
ted by macrophages and foamy cells. Foamy cells then 
die by in situ apoptosis, releasing non-degradable cho-
lesterol crystals, which become part of the core of the 
future atheromatous plaque.
Discussion
CVD is the most common cause of death in developed 
countries. The classic factors that predispose to CVD 
are identified: dyslipidemia, genetics, age, gender, high 
blood pressure, smoking, diabetes mellitus and metabol-
ic syndrome. Obvious risk factors for CVD such as obe-
sity and stress also appear to be related to PD. However, 
we must consider the emerging risk factors as biological 
markers: homocysteine, atherogenic lipoproteins, CRP 
and fibrinogen. These two factors reflect the levels of 
low intensity chronic systemic inflammation, as in the 
case of PD. This could be related to an increased risk of 
CVD (4-6). In fact, the PD-CVD association has been 
one amidst the most studied in recent years (7).
However, this link is difficult to prove because both dis-
eases share common risk factors (age, gender, smoking, 
oral hygiene habits or diabetes mellitus). In previous re-
views on the subject, some experts (1, 2) warned of the 
need to be cautious when affirming a causal relationship 
between PD-CVD, due to the difficulty of drawing con-
clusions based on the results of the studies reviewed . 
Besides, there are confounding factors that may not have 
been taken into consideration in certain clinical studies 
included in this review. In addition, the criteria for CVD 
and the diagnostic parameters for PD for each study 
could be different.
The determination of bacterial species, bacterial pro-
teins and lipopolysaccharide in the atheromatous pla-
ques which block coronary arteries has raised specu-
lation about the origin of these bacteria and what their 
reservoir is, finding that one of the possible places is the 
periodontal pocket (16). It has been observed that the 
distribution of periodontal pathogens in the gingival bio-
film is closely related to the levels of antibodies against 
these bacteria in blood (5). 
Periodontal bacteria would enter the bloodstream through 
the micro ulceration of the epithelium of the periodontal 
pocket. This entails a long-term systemic exposure of 
these pathogens. Once in the general circulation, they 
could play a direct or indirect role in the progression of 
atherosclerotic plaques in arterial lesions (16). The anti-
infective periodontal therapies, not only improve the cli-
nical symptoms, but also improve local antioxidant sta-
tus and systemic vascular endothelial dysfunction (28).
This was evident in experimental studies. As such by 
inoculating periodontal bacteria they observed greater 
vascular lesions. Through the increase of blood lipids 
systemic inflammation activates atherogenesis. This is 
the reason why periodontal diseases could enhance the 
accumulation of lipids and thus generate chronic infla-
mmations. The infectious agent by itself does not cause 
atherosclerosis, but seems to help accelerate its progres-
sion when the lesion is formed (12-14).
In clinical studies, one of the methods used to valida-
te the association between periodontal bacteria and the 
atheromatous plaque has been the detection of antibo-
dies against periodontal micro-organisms (5). Bacterial 
endotoxin and inflammatory mediators in relation to 
atheromatous lesions have been detected as well.
In addition, the DNA of microorganisms present in the 
bacterial plaque and in the atheromatous lesion has been 
directly identified. Finally, scientists have tried to relate 
directly the level of clinical periodontal lesions (blee-
ding and pocket depth) with the level of inflammation 
and cardiovascular injury (25).
There is plenty of epidemiological evidence with the 
data provided to date. This seems to confirm the role of 
periodontal damage by oral pathogens as a factor in the 
development of atherosclerosis. Yet, the quantification 
of this association remains unknown.
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